Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
Part of paid clinical trials in Loma Linda, California.
- Sponsor
- Loma Linda University
- Study ID
- NCT05551104
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- High Blood Pressure
- Maternal Hypertension
- Postpartum Complication
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Oral Nifedipine — DRUGAdministration of oral nifedipine to control postpartum hypertension.
- Oral Labetalol — DRUGAdministration of oral labetalol to control postpartum hypertension.
Study Details
The purpose of this investigator-initiated randomized control trial is to determine whether oral Nifedipine versus oral Labetalol is superior in controlling high blood pressures in the postpartum period.
Key Dates
- Start date
- May 8, 2023
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Oral NifedipineParticipants will receive oral nifedipine for blood pressure control. Dosage may initially start at one 10mg capsule by mouth three times per 24 hours (total of 30mg a day), however dosage may be increased by 30mg increments (i.e. 20mg capsule three times a day for a total of 60mg a day). Maximum dosage for oral Nifedipine will be 120mg per day.
- Active Comparator: Oral LabetalolParticipants will receive oral labetalol for blood pressure control. Dosage may initially start at one 200mg tablet by mouth two times per 12 hours (total of 400mg every a day), however dosage may be increased by 100-200mg increments at a time. Maximum dosage for oral labetalol will be 2400mg per day.
Primary Outcome Measure
Composite maternal morbidity [ Time Frame: 0-6 weeks following delivery ]
Central Contacts
- Ashra Denise B Tugung, BSc9096515580
- Nikia Gray-Hutto, RN, CCRP9095584000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loma Linda University Health | Loma Linda | California | 92350 | Ashra Tugung |
Find similar trials in Loma Linda, CA
By condition
By specialty
By research site
Related Studies
- Wearables to Define Postpartum Blood Pressure Trajectories and Facilitate Evidence-based Monitoring GuidelinesEnrolling By Invitation · University of California, San Diego · La Jolla, California
- Labor Education to Reduce Postpartum Traumatic StressEnrolling By Invitation · University of California, San Diego · San Diego, California
- Oura Blood Pressure Profile StudyRecruiting · Ouraring Inc. · San Francisco, California
- Blood Pressure Care for Advancing Real-World Evidence (BPCARE)Recruiting · University of California, San Diego · San Diego, California